Cargando…

Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab

BACKGROUND: Penile squamous cell carcinoma (PSCC) is a rare malignancy, and those patients with metastatic disease have limited treatment options. Treatment is largely comprised of platinum-based chemotherapy; however, patients progressing after initial chemotherapy have a median overall survival (O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chahoud, Jad, Skelton, William Paul, Spiess, Philippe E., Walko, Christine, Dhillon, Jasreman, Gage, Kenneth L., Johnstone, Peter A. S., Jain, Rohit K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793656/ https://www.ncbi.nlm.nih.gov/pubmed/33425770 http://dx.doi.org/10.3389/fonc.2020.615298

Ejemplares similares

An Analysis of Nectin-4 (PVRL4) in Penile Squamous Cell Carcinoma
por: Grass, G.Daniel, et al.
Publicado: (2023)

An Assessment of the Penile Squamous Cell Carcinoma Surfaceome for Biomarker and Therapeutic Target Discovery
por: Grass, George Daniel, et al.
Publicado: (2023)

An update on treatment of penile cancer
por: Chadha, Juskaran, et al.
Publicado: (2022)

The Immune Microenvironment in Penile Cancer and Rationale for Immunotherapy
por: Ahmed, Mohamed E., et al.
Publicado: (2020)

Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?
por: Adashek, Jacob J., et al.
Publicado: (2021)

The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma—A Systematic Review
por: Parza, Kevin, et al.
Publicado: (2023)

Pembrolizumab as a promising intervention for advanced penile cancer
por: Vinueza-Obando, Daniela, et al.
Publicado: (2022)

Prognostic predictors of lymph node metastasis in penile cancer: a systematic review
por: Zekan, David S., et al.
Publicado: (2021)

Penile cancer: Updates in systemic therapy
por: Joshi, Vidhu B., et al.
Publicado: (2022)

Major Durable Response of Pembrolizumab in Chemotherapy Refractory Small Cell Bladder Cancer: A Case Report
por: Nguyen, Olav Toai Duc, et al.
Publicado: (2020)

Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report
por: Zeng, Tian, et al.
Publicado: (2021)

Effective combinatorial immunotherapy for penile squamous cell carcinoma
por: Huang, Tianhe, et al.
Publicado: (2020)

Combination of Pembrolizumab and Stereotactic Body Radiation Therapy in Recurrent Metastatic Penile Squamous Cell Carcinoma: A Case Study
por: Kaakour, Dalia, et al.
Publicado: (2022)

Pembrolizumab-Induced Vitiligo in Esophageal Squamous Cell Carcinoma Patient With Durable Complete Response
por: Wilkins, Matthew C, et al.
Publicado: (2021)

Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma
por: Chatwal, Monica Sheila, et al.
Publicado: (2023)

Pembrolizumab for Refractory Metastatic Myxofibrosarcoma: A Case Report
por: Song, Haa-Na, et al.
Publicado: (2018)

Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma
por: Kao, Chien-Hsiang, et al.
Publicado: (2022)

Nivolumab to pembrolizumab switch induced a durable melanoma response: A case report
por: Lepir, Tanja, et al.
Publicado: (2019)

Pembrolizumab and palliative radiotherapy in 2 cases of refractory mycosis fungoides
por: Walker, Christina J., et al.
Publicado: (2020)

Dramatic response of refractory metastatic squamous cell carcinoma of the skin with cetuximab/pembrolizumab
por: Hober, Candice, et al.
Publicado: (2021)

Robust and durable response to first-line treatment of pembrolizumab combined with chemotherapy in two patients with metastatic thymic squamous cell carcinoma: Case report
por: Chen, Cui, et al.
Publicado: (2022)

Changing Radiotherapy Paradigms in Penile Cancer
por: Johnstone, Peter A.S., et al.
Publicado: (2022)

A complete durable response of vaginal clear cell carcinoma with pembrolizumab: A case report
por: Porragas-Paseiro, Hector S., et al.
Publicado: (2023)

Updates in the use of radiotherapy in the management of primary and locally-advanced penile cancer
por: Patel, Akshar, et al.
Publicado: (2022)

Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma
por: Zhang, Yumeng, et al.
Publicado: (2022)

Management of penile cancer
por: Spiess, Philippe E., et al.
Publicado: (2017)

Rare case of chemotherapy-refractory metastatic vaginal squamous cell carcinoma with complete response to concurrent pembrolizumab and radiotherapy- case report and literature review
por: Ansari, Jawaher, et al.
Publicado: (2021)

Pembrolizumab in relapsed or refractory Richter syndrome
por: Armand, Philippe, et al.
Publicado: (2020)

The Goal of Achieving High-Quality Surgical First-Line Therapy in Patients with Penile Cancer Is Important; However, Some Collective Efforts Are Still Required in Order to Reach It. Comment on Brassetti et al. Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The Tetrafecta Achievement. Curr. Oncol. 2023, 30, 1882–1892
por: May, Matthias, et al.
Publicado: (2023)

Prognostic Significance of p16 and Its Relationship with Human Papillomavirus Status in Patients with Penile Squamous Cell Carcinoma: Results of 5 Years Follow-Up
por: Chahoud, Jad, et al.
Publicado: (2022)

A Case Report of Refractory Penile Squamous Cell Carcinoma Treated With Surgical Resection, Chemotherapy and External Beam Radiation Therapy
por: Zong, Perry, et al.
Publicado: (2023)

Management of pembrolizumab-induced steroid refractory mucositis with infliximab: A case report
por: Dang, Harry, et al.
Publicado: (2020)

Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab
por: Wang, Wei Cen, et al.
Publicado: (2023)

Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation
por: van Baar, Mireille L.M., et al.
Publicado: (2019)

Warthy-Basaloid Squamous Cell Carcinoma of Penile – Case Report
por: Domian, Natalia, et al.
Publicado: (2021)

Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
por: Cyriac, Sanju, et al.
Publicado: (2021)

Complete and durable response of pulmonary large‐cell neuroendocrine carcinoma to pembrolizumab
por: Kadota, Naoki, et al.
Publicado: (2021)

Durable response to pembrolizumab in microsatellite instability‐high advanced adrenocortical carcinoma
por: Senda, Masaya, et al.
Publicado: (2023)

Implications of Programmed Death Ligand-1 Positivity in Non-Clear Cell Renal Cell Carcinoma
por: Chipollini, Juan, et al.
Publicado: (2018)

Durable response to the combination of pembrolizumab and nab-paclitaxel in a metastatic extrahepatic cholangiocarcinoma: A case report and literature review
por: Tan, Sirui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_14qg6rb50i9uoskciko06ig511